The Prescription Drug Marketing Act (PDMA) was enacted on April 22, 1988 (Public Law 100-293) to respond to problems relating to the safety, efficacy, storage and handling of pharmaceuticals. PDMA established specific requirements for the selling and distribution of prescription drugs.

Included in these is a requirement that wholesale distributors of prescription drugs be state licensed according to FDA minimum standards. The final rule includes provisions dealing with the “authorized distributor of record” and “drug pedigree” elements of PDMA.

Capital Drug Company is an ‘authorized distributor of record’ and capable of providing our customers with on-demand access to “drug pedigree” on all purchases.